At the end of the inspection, the facility received two observations, one on written production process control procedure and the other on investigation procedure
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
Both products are broad-spectrum, foliar insecticides used across wide range of crops
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole
NATCO to sell 15% of shareholding in Nativita for euro 3,45,000 to Pharmasyntez-Nord
According to industry sales data, Yondelis generated annual sales of $49.7 million for the twelve months ending June 2022 in the US market.
He has over 25+ years of experience in the pharmaceutical Industry and has been working with the company for the past 6 years
The company has reported total income of Rs. 918.9 crores during the period ended June 30, 2022.
The product will be launched by NATCO's commercial partner Viatris.
Subscribe To Our Newsletter & Stay Updated
